What does MEDICHIN do?

MEDICHIN is a wholesaler in Diepenbeek. Public Limited, started on 12 August 1987, 1 establishment.

What is the address of MEDICHIN?

The registered office of MEDICHIN is located at Groeningenweg 15, 3590 Diepenbeek.

Is MEDICHIN still active?

Yes. According to the CBE (29 October 2026) MEDICHIN is active, legal situation “Normale toestand”, started on 12 August 1987.

Is MEDICHIN registered on Peppol?

Yes, MEDICHIN is registered on the Peppol network with ID 0208:0431756304.

What is the enterprise number of MEDICHIN?

The enterprise number of MEDICHIN is BE0431756304.

When was MEDICHIN founded?

MEDICHIN was founded on 12 August 1987.

Who are the directors of MEDICHIN?

According to the 2025 annual accounts, the directors of MEDICHIN are: CM Holding BV, Ghislain Crommen, Sara Bervoets.

Is MEDICHIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 August 1987; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did MEDICHIN make in 2025?

MEDICHIN posted a profit after taxes of € 1,029,304 in financial year 2025.

What is the revenue of MEDICHIN?

As a small company, MEDICHIN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,692,043.

How much does an employee at MEDICHIN earn?

The average wage cost per full-time employee at MEDICHIN was € 52,400 in 2025: staff costs of € 456,156 for 8.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MEDICHIN have?

According to the 2025 annual accounts, MEDICHIN has 8.7 full-time equivalents (FTE).

MEDICHIN (Public Limited) - Diepenbeek - BE0431756304

Dossier MEDICHIN, printed on 29 October 2026 from databakkes.be/en/0431756304/medichin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDICHIN from Diepenbeek, company number BE0431756304, closed financial year 2025 with a result of € 1 million after tax. For that financial year MEDICHIN recorded a gross margin of € 1.7 million and equity of € 2.2 million. Compared with financial year 2024, the result moved from € 1.3 million to € 1 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 22, 2026.

What it is worth Healthy

€ 2.2 million

▼ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 1 million

▼ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.2 million

▲ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1.2 million paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

8.7

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 456,156

▲ 4% vs 2024

€ 52,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 69,406

▼ 9% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 86,219

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 58,278

▼ 20% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,689,412 Gross margin 2022: € 1,689,412 First fiscal year in the series	€ 1,709,044 Gross margin 2023: € 1,709,044 ▲ 1% vs 2022 (€ 1,689,412) Favourable step	€ 2,039,613 Gross margin 2024: € 2,039,613 ▲ 19% vs 2023 (€ 1,709,044) Favourable step	€ 1,692,043 Gross margin 2025: € 1,692,043 ▼ 17% vs 2024 (€ 2,039,613) Unfavourable step	▼ 17%
Profit after taxes	€ 945,005 Profit after taxes 2022: € 945,005 First fiscal year in the series	€ 926,601 Profit after taxes 2023: € 926,601 ▼ 2% vs 2022 (€ 945,005) Unfavourable step	€ 1,276,536 Profit after taxes 2024: € 1,276,536 ▲ 38% vs 2023 (€ 926,601) Favourable step	€ 1,029,304 Profit after taxes 2025: € 1,029,304 ▼ 19% vs 2024 (€ 1,276,536) Unfavourable step	▼ 19%
Equity	€ 2,324,078 Equity 2022: € 2,324,078 First fiscal year in the series	€ 2,420,679 Equity 2023: € 2,420,679 ▲ 4% vs 2022 (€ 2,324,078) Favourable step	€ 2,284,408 Equity 2024: € 2,284,408 ▼ 6% vs 2023 (€ 2,420,679) Unfavourable step	€ 2,162,179 Equity 2025: € 2,162,179 ▼ 5% vs 2024 (€ 2,284,408) Unfavourable step	▼ 5%
Total debts	€ 1,084,437 Total debts 2022: € 1,084,437 First fiscal year in the series	€ 1,125,484 Total debts 2023: € 1,125,484 ▲ 4% vs 2022 (€ 1,084,437) Unfavourable step	€ 1,622,967 Total debts 2024: € 1,622,967 ▲ 44% vs 2023 (€ 1,125,484) Unfavourable step	€ 1,347,291 Total debts 2025: € 1,347,291 ▼ 17% vs 2024 (€ 1,622,967) Favourable step	▼ 17%
Cash	€ 1,206,472 Cash 2022: € 1,206,472 First fiscal year in the series	€ 605,083 Cash 2023: € 605,083 ▼ 50% vs 2022 (€ 1,206,472) Unfavourable step	€ 970,040 Cash 2024: € 970,040 ▲ 60% vs 2023 (€ 605,083) Favourable step	€ 1,175,396 Cash 2025: € 1,175,396 ▲ 21% vs 2024 (€ 970,040) Favourable step	▲ 21%
Retained profit	€ 2,262,078 Retained profit 2022: € 2,262,078 First fiscal year in the series	€ 2,358,679 Retained profit 2023: € 2,358,679 ▲ 4% vs 2022 (€ 2,262,078) Favourable step	€ 2,222,408 Retained profit 2024: € 2,222,408 ▼ 6% vs 2023 (€ 2,358,679) Unfavourable step	€ 2,100,179 Retained profit 2025: € 2,100,179 ▼ 5% vs 2024 (€ 2,222,408) Unfavourable step	▼ 5%
Dividend	€ 850,000 Dividend 2022: € 850,000 First fiscal year in the series	€ 830,000 Dividend 2023: € 830,000 ▼ 2% vs 2022 (€ 850,000) Unchanged	€ 1,412,806 Dividend 2024: € 1,412,806 ▲ 70% vs 2023 (€ 830,000) Unchanged	€ 1,151,533 Dividend 2025: € 1,151,533 ▼ 18% vs 2024 (€ 1,412,806) Unchanged	▼ 18%
Balance sheet total	€ 3,408,516 Balance sheet total 2022: € 3,408,516 First fiscal year in the series	€ 3,546,163 Balance sheet total 2023: € 3,546,163 ▲ 4% vs 2022 (€ 3,408,516) Unchanged	€ 3,907,375 Balance sheet total 2024: € 3,907,375 ▲ 10% vs 2023 (€ 3,546,163) Unchanged	€ 3,509,470 Balance sheet total 2025: € 3,509,470 ▼ 10% vs 2024 (€ 3,907,375) Unchanged	▼ 10%
Employees (FTE)	9.1 Employees (FTE) 2022: 9.1 First fiscal year in the series	8.7 Employees (FTE) 2023: 8.7 ▼ 0.4 vs 2022 (9.1) Unchanged	8.6 Employees (FTE) 2024: 8.6 ▼ 0.1 vs 2023 (8.7) Unchanged	8.7 Employees (FTE) 2025: 8.7 ▲ 0.1 vs 2024 (8.6) Unchanged	▲ 0.1

Key figures of MEDICHIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDICHIN?

What happened at MEDICHIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 CM Holding BV stepped down as director. NBB
2029 Ghislain Crommen stepped down as director. NBB
2029 Sara Bervoets stepped down as director. NBB
May 22, 2026 New annual accounts for financial year 2025: profit of € 1 million (▼ 19% vs 2024). Source: NBB ↗
2023 CM Holding BV became a director. NBB
2023 Ghislain Crommen became a director. NBB
2023 Sara Bervoets became a director. NBB
Sep 23, 1987 New establishment in Diepenbeek. KBO

In short

From € 945,005 profit in 2022 to € 1 million profit in 2025.

Paid € 187,363 in corporate taxes since 2022.

Best year ever: 2024, with € 1.3 million profit.

On average € 194,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

CM Holding BV

Managing director · represented by Miguel Crommen

Also active at: DIEPENBEEK MARKT FARMA

since 2023 · until 2029

Ghislain Crommen

Director

Also active at: DIEPENBEEK MARKT FARMA

since 2023 · until 2029

Sara Bervoets

Director

since 2023 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Groeningenweg 15

3590 Diepenbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

Memory

€ 325,428 gross margin · 2025

ERIAN

€ 12,084 gross margin · 2025

CM HOLDING same network

€ 1.2 million gross margin · 2025

M-S-M

M-M

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0431.756.304

VAT number

BE 0431.756.304

Registered office

Groeningenweg 15, 3590 Diepenbeek

Names & denominations

MEDICHIN

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

12 August 1987

Peppol

Active · Active since 10 Dec 2025

Activities · NACE

Groothandel in koffie, thee, cacao en specerijen

Groothandel in andere voedingsmiddelen, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDICHIN

Financials

What happened to MEDICHIN?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions